Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment

Endocrine-Related Cancer

Volumn 14, Issue 4, 2007, Pages 1107-1116

  Yoshimura, T ^a   Sumida, T ^a,b   Liu, S ^a   Onishi, A ^a,b   Shintani, S ^a   Desprez, P Y ^b   Hamakawa, H ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 1; MYC PROTEIN; PROGESTERONE RECEPTOR; PROTEIN P21;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; DOWN REGULATION; HUMAN; HUMAN CELL; RECEPTOR UPREGULATION; SALIVARY GLAND CANCER; TUMOR CELL;

BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; NEOPLASM INVASIVENESS; PROGESTERONE; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS; TELOMERASE;

EID: 39149124150     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01253     Document Type: Article

References (46)

1. Clarke CL & Sutherland R 1990 Progestin regulation of cellular proliferation. Endocrine Reviews 11 266-301.
2. Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ & Campisi J 1998 A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Molecular and Cellular Biology 18 4577-4588.
3. Graham JD & Clarke CL 1997 Physiological action of progesterone in target tissues. Endocrine Reviews 18 502-519.
4. Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA & Horwitz KB 1997 Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Molecular Endocrinology 11 1593-1607.
5. Guan XF, Qiu WL, He RG & Zhou XJ 1997 Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. International Journal of Oral and Maxillofacial Surgery 26 116-119.
6. Horwitz KB 1993 Mechanisms of hormone resistance in breast cancer. Breast Cancer Research and Treatment 26 119-130.
7. Ishibashi H, Suzuki T, Suzuki S, Niikawa H, Lu L, Miki Y, Moriya T, Hayashi S, Handa M, Kondo T et al. 2005 Progesterone receptor in non-small cell lung cancer - a potent prognostic factor and possible target for endocrine therapy. Cancer Research 65 6450-6458.
8. Jones AS, Hamilton JW, Rowley H, Husband D & Helliwell TR 1997 Adenoid cystic carcinoma of the head and neck. Clinical Otolaryngology and Allied Sciences 22 434-443.
9. Kastner P, Bocquel MT, Turcotte B, Garnier JM, Horwitz KB, Chambon P & Gronemeyer H 1990 Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. Journal of Biological Chemistry 265 12163-12167.
10. Kauppila A, Kujansuu E & Vihko R 1982 Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin. Clinical correlates. Cancer 50 2157-2162.
11. Kester HA, van der Leede BM, van der Saag PT & van der Burg B 1987 Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. Journal of Biological Chemistry 272 16637-16643.
12. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL & Shay JW 1994 Specific association of human telomerase activity with immortal cells and cancer. Science 266 2011-2015.
13. Knight WA III, Osborne CK, Yochmowitz MG & McGuire WL 1980 Steroid hormone receptors in the management of human breast cancer. Annals of Clinical Research 12 202-207.
14. Lebeau J, Fouchet P, Ory K & Chevillard S 2002 Down-regulation of telomerase activity after progesterone treatment of human breast cancer cells: essential role of the cell cycle status. Anticancer Research 22 2161-2166.
15. Lima SS, Soares AF, Amorim RF & Freitas RD 2005 Epidemiologic profile of salivary gland neoplasms: analysis of 245 cases. Revista Brasileira de Otorrinolaringologia 71 335-340.
16. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J & Desprez PY 2000a A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Research 60 1332-1340.
17. Lin VC, Ng EH, Aw SE, Tan MG, Ng EH & Bay BH 2000b Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor complementary DNA. Molecular Endocrinology 14 348-358.
18. Lin VC, Eng AS, Hen NE, Ng EH & Chowdhury SH 2001 Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB231. Clinical Cancer Research 7 2880-2886.
19. Lopes MA, Santos GC & Kowalski LP 1998 Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head and Neck 20 699-706.
20. Maniatis T, Fritsch EF & Sambrook J 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
21. Marandas P, Dharkar D, Davis A, Leridant AM, Pacheco Ojeda L, Micheau C, Wibault P & Schwaab G 1990 Malignant tumours of the parotid: a study of 76 patients. Clinical Otolaryngology 15 103-109.
22. McGuire WL & Clark GM 1985 Role of progesterone receptors in breast cancer. Seminars in Oncology 12 12-16.
23. Munstedt K, Steen J, Knauf AG, Buch T, von Georgi R & Franke FE 2000 Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 89 1783-1791.
24. Osborne CK & Fuqua SAW 1994 Mechanisms of tamoxifen resistance. Breast Cancer Research and Treatment 32 49-55.
25. Osborne CK, Yochmowitz MG, Knight WA III & McGuire WL 1980 The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46 2884-2888.
26. Ozono S, Onozuka M, Sato K & Ito Y 1992 Immunohistochemical localization of estradiol, progesterone, and progesterone receptor in human salivary glands and salivary adenoid cystic carcinomas. Cell Structure and Function 17 169-175.
27. Pia-Foschini M, Filho JS, Eusebi V & Lakhani SR 2003 Salivary gland-like tumours of the breast: surgical and molecular pathology. Journal of Clinical Pathology 56 497-506.
28. Rove RR 1989 Tamoxifen therapy in primary breast cancer: biology, efficacy and side effects. Journal of Clinical Oncology 7 803-815.
29. Sato M 1993 Differentiation therapy for salivary gland tumors. Gan To Kagaku Ryoho 20 1028-1036.
30. Shick PC, Riordan GP & Foss RD 1995 Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 80 440-444.
31. Sitruk-Ware R, Plu-Bureau G, Birrell SN, Hall RE & Tilley WD 1999 Progestins and cancer. Gynecological Endocrinology 4 3-9.
32. Spiro RH 1997 Distant metastasis in adenoid cystic carcinoma of salivary origin. American Journal of Surgery 174 495-498.
33. Spiro RH, Huvos AG & Strong EW 1974 Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. American Journal of Surgery 128 512-520.
34. Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H & Ueda N 1999 Telomerase components as a diagnostic tool in human oral lesions. International Journal of Cancer 80 1-4.
35. Sumida T, Itahana Y, Hamakawa H & Desprez PY 2004 Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form A or B of the progesterone receptor and then treatment with progestins. Cancer Research 64 7886-7892.
36. Szanto PA, Luna MA, Tortoledo ME & White RA 1984 Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 54 1062-1069.
37. Takagi D, Fukuda S, Furuta Y, Yagi K, Homma A, Nagahashi T & Inuyama Y 2001 Clinical study of adenoid cystic carcinoma of the head and neck. Auris, Nasus, Larynx 28 99-102.
38. Teymoortash A, Lippert BM & Werner JA 2001 Steroid hormone receptors in parotid gland cystadenolymphoma (Warthin's tumour). Clinical Otolaryngology 26 411-416.
39. Toida M, Shimokawa K, Makita H, Kato K, Kobayashi A, Kusunoki Y, Hatakeyama D, Fujitsuka H, Yamashita T & Shibata T 2005 Intraoral minor salivary gland tumors: a clinicopathological study of 82 cases. International Journal of Oral and Maxillofacial Surgery 34 528-532.
40. Tong D, Schuster E, Seifert M, Czerwenka K, Leodolte S & Zeillinger R 2002 Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Breast Cancer Research and Treatment 71 249-255.
41. Ueta E, Osaki T, Yamamoto T & Yoneda K 1998 Induction of differentiation in maxillary adenoid cystic carcinomas by adoptive immunotherapy in combination with chemoradiotherapy. Oral Oncology 34 105-111.
42. Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K et al. 2000 Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Research 60 5376-5381.
43. Wen DX, Xu YF, Mais DE, Goldman ME & McDonnell DP 1994 The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Molecular and Cellular Biology 14 8356-8364.
44. Wick MR, Ockner M, Mills SE, Ritter JH & Swanson PE 1998 Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. American Journal of Clinical Pathology 109 75-84.
45. Young PC, Ehrlich CE & Einhorn LH 1980 Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer. Cancer 46 2961-2963.
46. Zhang Y, Wang H, Toratani S, Sato JD, Kan M, McKeehan WL & Okamoto T 2001 Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. PNAS 98 11336-11340.